Key statistics
As of last trade, Scinai Immunotherapeutics Ltd (SCNI:NAQ) traded at 3.75, 68.16% above the 52 week low of 2.23 set on Jun 10, 2024.
52-week range
Open | 3.95 |
---|---|
High | 4.31 |
Low | 3.61 |
Bid | 3.75 |
Offer | 3.83 |
Previous close | 4.53 |
Average volume | 62.04k |
---|---|
Shares outstanding | 210.00 |
Free float | -- |
P/E (TTM) | -- |
Market cap | 3.79m USD |
EPS (TTM) | -9.04 USD |
Data delayed at least 15 minutes, as of Sep 19 2024 16:05 BST.
More ▼
- Scinai Immunotherapeutics Announces Award of Non-Dilutive Grant from Israel Innovation Authority Supporting its New CDMO Business Unit
- Scinai Immunotherapeutics Provides Update Regarding Nasdaq Compliance
- European Investment Bank (EIB) considering extending maturity of its financial facility contract with Scinai Immunotherapeutics in light of Scinai’s recent strategic pivot
- Scinai Reports Third Quarter 2023 Financial Results and Provides Business Update
- Scinai Immunotherapeutics to Attend BIO-Europe Munich 2023
- Scinai Immunotherapeutics to Showcase its end-to-end cGMP Biologics CDMO Services at CPHI Barcelona 2023
- Scinai Immunotherapeutics Announces Closing of $1.33 Million Registered Direct Offering
More ▼